학술논문

Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ART.
Document Type
article
Source
JAIDS Journal of Acquired Immune Deficiency Syndromes. 81(1)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Prevention
Infectious Diseases
Kidney Disease
Evaluation of treatments and therapeutic interventions
6.1 Pharmaceuticals
Adult
Anti-HIV Agents
Drug Substitution
Female
Glomerular Filtration Rate
HIV Infections
Humans
Kidney Diseases
Male
Middle Aged
Proportional Hazards Models
Retrospective Studies
kidney dysfunction
HIV
antiretroviral therapy
durability
tenofovir
Public Health and Health Services
Virology
Clinical sciences
Epidemiology
Public health
Language
Abstract
BackgroundAntiretroviral therapy (ART) durability, time to modification or cessation, has declined. The study objective was to determine whether kidney dysfunction is contributing to reduced durability.MethodsThis retrospective follow-up study of CNICS evaluated treatment-naive PLWH initiating ART between 2007 and 2014. Regimen modification was defined as cessation/modification of any part of the 3-drug ART regimen. We evaluated the role of kidney dysfunction in initial regimen modification as both a mediator and effect measure modifier. Associations of the variables with the ART modification were examined using univariable and multivariable Cox proportional hazard models.ResultsOf 4515 PLWH included in the analysis, 1967 modified their ART. Of those receiving TDF-based ART (n = 3888), 1580 (41%) modified their regimen compared with 387 (62%) receiving other regimens. Overall, the median eGFR decreased by 5 mL/min/1.73 m (quartiles: first = -16, third = 0) from baseline to follow-up. Of the 128 patients with low baseline eGFR (